Fragile X syndrome.
The physical, psychological, and cytogenetic characteristics of individuals with the Fragile X syndrome were reviewed. Prospects for therapy with folic acid, prenatal diagnosis, phenotype of heterozygotes for the marker X, and unresolved issues about the syndrome were discussed.
D000293:Adolescent; D002648:Child; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D005600:Fragile X Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D005817:Genetic Counseling; D005819:Genetic Markers; D006579:Heterozygote; D006801:Humans; D007223:Infant; D008607:Intellectual Disability / Q000209:etiology; D008297:Male; D010641:Phenotype; D011296:Prenatal Diagnosis; D012729:Sex Chromosome Aberrations / Q000235:genetics*; D013737:Testis / Q000473:pathology
D005819:Genetic Markers; D005492:Folic Acid